{"id":103122,"date":"2023-05-19T14:20:02","date_gmt":"2023-05-19T08:50:02","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=103122"},"modified":"2023-05-19T14:20:04","modified_gmt":"2023-05-19T08:50:04","slug":"pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/","title":{"rendered":"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3175141377\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>With a market capitalization of Rs 17,550 crores, Gland Pharma Limited\u2019s stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2572915750\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Such a sharp movement in the stock prices is observed after the company announced its Q4 as well as annual results for the financial year 2022-2023. Details of the same are discussed later on in the piece.&nbsp;<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLAND\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Gland Pharma Limited<\/a><\/strong> is engaged in the process of manufacturing, development, and marketing of complex injectables. Its key molecules include Enoxaparin Sodium Injection, Daptomycin Injection, Heparin Sodium Injection, etc.\u00a0<\/p><p>In addition, the company is also involved in a vast range of therapeutic categories including Anesthetics, Anti-Infectives, etc. Geographically, it derives a majority of its revenue from the United States of America.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3524433564\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Having a walkthrough of the financials, the company, on a QoQ basis, has reported a decline as far as the operating revenues and net profits are concerned. The operating revenues moved down from Rs 938 crores in Q3 to Rs 785 crores in Q4. Moreover, the net profits went down from Rs 232 crores to Rs 79 crores representing a decline of around 66 percent.&nbsp;<\/p><p>On a YoY basis as well, the company has underperformed with a downfall in the above-mentioned metrics. The operating revenues reduced from Rs 4,400 crores during FY21-22 to Rs 3,625 crores in FY22-23 and net profits, keeping the timeframe the same, slipped from Rs 1,212 crores to Rs 781 crores indicating a 36 percent decrease.&nbsp;<\/p><p>Coming onto the basic margin ratios of the company, the EBITDA margins as well as PAT margins have gone down on a sequential basis with the former going down from 31 percent during Q3 to 21 percent in Q4 and the latter moving from 25 percent to 10 percent in the same time horizon.&nbsp;<\/p><p>As per the latest shareholding pattern data available for the March quarter, promoters hold a 57.86 percent stake, and Foreign Institutional Investors hold a 4.32 percent stake in the company.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Amit Madnani<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-586509486\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>With a market capitalization of Rs 17,550 crores, Gland Pharma Limited\u2019s stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.&nbsp; Such a sharp movement in the stock prices is observed after the company announced its Q4 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":13575,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[6115,9340,9342,9339,6162,9253,948,936,9341],"class_list":["post-103122","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-20-lower-circuit","tag-gland-pharma-latest-news","tag-gland-pharma-q4-results2023","tag-gland-pharma-share-price","tag-mid-cap-stock-to-buy-now","tag-mid-cap-stocks-2023","tag-stock-market","tag-stock-market-news","tag-why-is-gland-pharma-going-down"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0\" \/>\n<meta property=\"og:description\" content=\"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-19T08:50:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-19T08:50:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/\",\"name\":\"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg\",\"datePublished\":\"2023-05-19T08:50:02+00:00\",\"dateModified\":\"2023-05-19T08:50:04+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg\",\"width\":1280,\"height\":854,\"caption\":\"nifty Sensex\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0 - Trade Brains Features","description":"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0","og_description":"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-05-19T08:50:02+00:00","article_modified_time":"2023-05-19T08:50:04+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/","name":"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg","datePublished":"2023-05-19T08:50:02+00:00","dateModified":"2023-05-19T08:50:04+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"With a market capitalization of Rs 17,550 crores, the company stock started its trading session today at Rs 1,160, and, as of 10:00 am, the scrip is locked in the 20 percent lower circuit marked at Rs 1,065.60.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Markets-down-2-Cover-Image-.jpg","width":1280,"height":854,"caption":"nifty Sensex"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-lower-circuit-after-company-posts-66-decline-in-net-profit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 20% lower circuit after company posts 66% decline in net profit \u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=103122"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103122\/revisions"}],"predecessor-version":[{"id":103125,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/103122\/revisions\/103125"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/13575"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=103122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=103122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=103122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}